Finance

Lists
Why is ORCHPHARMA down ၂.၀၅%?
Dive Deeper
ORCHPHARMA:NSE
Orchid Pharma Ltd
၉၀၉.၀၀ ₹
-၂.၀၅%
(-၁၉.၀၅) 1D
အောက် ၁၆, GMT+၅:၃၀ ၁၅:၃၀:၀၀  ·   INR
All symbols
SymbolPriceChange% Change
Generating top insights for ORCHPHARMA...
Open
၉၃၅.၀၀ ₹
High
၉၃၈.၉၅ ₹
Low
၈၉၆.၀၀ ₹
Mkt. cap
ဋေ ၅.၄၄ ထ
Avg. vol.
၁.၀၆ သိန်း
Volume
၁.၀၅ သိန်း
52-wk high
၁,၁၄၃.၅၀ ₹
52-wk low
၄၈၀.၀၀ ₹
EPS
-၀.၈၈ ₹
No. of employees
၁ ထောင်
Open
၉၃၅.၀၀ ₹
High
၉၃၈.၉၅ ₹
Low
၈၉၆.၀၀ ₹
Mkt. cap
ဋေ ၅.၄၄ ထ
Avg. vol.
၁.၀၆ သိန်း
Volume
၁.၀၅ သိန်း
52-wk high
၁,၁၄၃.၅၀ ₹
52-wk low
၄၈၀.၀၀ ₹
EPS
-၀.၈၈ ₹
No. of employees
၁ ထောင်
News stories
From web sources and news partners
Simply Wall Street
Simply Wall Street
·
ပြီးခဲ့သည့် ၂၇ မိနစ်
What Kiniksa Holders Bought Into Before A 87% Run
The Motley Fool
The Motley Fool
·
ပြီးခဲ့သည့် ၂၅ မိနစ်
Ethereum Dramatically Outperformed the S&P 500 in Q3. Is It Finally Time to Load Up on Ethereum?
Benzinga
Benzinga
·
ပြီးခဲ့သည့် ၄၈ မိနစ်
S&P 500 Index Outlook: Strong Earnings Meet AI Rout, $110 Oil Prices
Yahoo Finance
Yahoo Finance
·
ပြီးခဲ့သည့် ၆ နာရီ
Wall Street’s record breakouts unravel as investors dump recent winners: Chart of the Day
Profile
Orchid Pharma Limited is an Indian pharmaceutical company based in Chennai. It was founded by Kailasam Raghavendra Rao on 1 July 1992. Orchid Pharma is the only pharma company in India to have discovered a New Drug Enmetazobactam which is now approved in United States, Europe and India. Wikipedia
About Orchid Pharma Ltd
CEO-
Employees၁.၁၇ ထောင်
Founded၁၉၉၂
Headquarters-
Sector-
Last report
၂၀၂၆ ဩ ၂၁
Fiscal period
Q1 2027
၀.၅၄ ₹ / ၃.၆၀ ₹
-၈၅.၀၀%miss
Revenue / Est. (INR)
၃၀၄.၁၇ ဋေ / ၂၃၀.၅၀ ဋေ
+၃၁.၉၆%beat
Fiscal Q1 2027 earnings call
Waiting for the earnings call
At a glance
Insights from the latest news and reports
Previous reportsAll values in INR
Loading Previous Earnings...
Revenue
Net income
All values in INR
၂၀၂၅ စက်
၂၀၂၅ ဒီ
၂၀၂၆ မတ်
၂၀၂၆ ဇွန်
Revenue
၁၉၃.၅၂ ဋေ
၂၀၇.၂၇ ဋေ
၆၅၉.၀၆ ဋေ
၃၀၄.၁၇ ဋေ
Cost of goods sold
၁၃၂.၅၁ ဋေ
၁၄၃.၁၅ ဋေ
၅၀၂.၉၀ ဋေ
၂၀၄.၃၀ ဋေ
Cost of revenue
၁၃၂.၅၁ ဋေ
၁၄၃.၁၅ ဋေ
၅၀၂.၉၀ ဋေ
၂၀၄.၃၀ ဋေ
Research and development expenses
-
-
-
-
Total research and development expenses
-
-
-
-
Selling, general, and admin expenses
၂၄.၈၅ ကုဋေ
၂၄.၁၃ ကုဋေ
၅၀.၂၃ ကုဋေ
၂၈.၀၄ ကုဋေ
Operating expense
၇၁.၃၉ ကုဋေ
၇၁.၅၉ ကုဋေ
၁၃၉.၇၈ ဋေ
၉၆.၈၂ ကုဋေ
Total operating expenses
၂၀၃.၉၀ ဋေ
၂၁၄.၇၃ ဋေ
၆၄၂.၆၈ ဋေ
၃၀၁.၁၂ ဋေ
Operating income
-၁၀.၃၈ ကုဋေ
-၇.၄၇ ကုဋေ
၁၆.၃၈ ကုဋေ
၃.၀၅ ကုဋေ
Other non operating income
၁၀.၇၇ ကုဋေ
၅.၆၁ ကုဋေ
-၂၃.၈၀ ကုဋေ
၁.၈၃ ကုဋေ
EBT including unusual items
-၅.၇၂ ကုဋေ
-၁၂.၆၁ ကုဋေ
၁၃.၁၉ ကုဋေ
၃.၃၀ ကုဋေ
EBT excluding unusual items
-၅.၇၂ ကုဋေ
-၅.၅၀ ကုဋေ
၅.၄၉ ကုဋေ
၃.၃၀ ကုဋေ
Income tax expense
-
-
၁.၇၀ သောင်း
၇.၂၃ သိန်း
Effective tax rate
-
-
၀.၀၁%
၂.၁၉%
Other operating expenses
၃၇.၆၄ ကုဋေ
၃၈.၄၃ ကုဋေ
၄၁.၉၃ ကုဋေ
၅၇.၈၃ ကုဋေ
Net income
-၅.၇၂ ကုဋေ
-၁၂.၆၁ ကုဋေ
၁၃.၁၉ ကုဋေ
၃.၂၂ ကုဋေ
Net profit margin
-၂.၉၆%
-၆.၀၉%
၂.၀၀%
၁.၀၆%
Earnings per share
-၁.၁၃
-၁.၀၈
၄.၅၈
၀.၅၄
Interest and investment income
-
-
၁၀.၁၂ ကုဋေ
-
Interest expense
-၃.၇၃ ကုဋေ
-၃.၁၈ ကုဋေ
-
-၂.၂၃ ကုဋေ
Net interest expenses
-၃.၇၃ ကုဋေ
-၃.၁၈ ကုဋေ
၁၀.၁၂ ကုဋေ
-၂.၂၃ ကုဋေ
Depreciation and amortization charges
၈.၉၀ ကုဋေ
၉.၀၃ ကုဋေ
၁၆.၆၆ ကုဋေ
၁၀.၉၅ ကုဋေ
EBITDA
-၁.၆၀ ကုဋေ
၁.၀၅ ကုဋေ
၂၆.၉၆ ကုဋေ
၁၁.၉၁ ကုဋေ
Gain or loss from assets sale
-
-
-
-
AI content may include mistakes. Learn more
Google အက်ပ်များ